{"meshTagsMajor":["Mutation","Reproductive Techniques, Assisted"],"keywords":["BRCA1","BRCA2","infertility","inÂ vitro fertilization","ovarian cancer"],"meshTags":["Adult","Aged","BRCA1 Protein","BRCA2 Protein","Case-Control Studies","Chi-Square Distribution","DNA Mutational Analysis","Female","Fertility","Fertility Agents, Female","Fertilization in Vitro","Genetic Predisposition to Disease","Humans","Infertility","Insemination, Artificial","Logistic Models","Middle Aged","Multivariate Analysis","Mutation","Odds Ratio","Ovarian Neoplasms","Pregnancy","Reproductive Techniques, Assisted","Risk Assessment","Risk Factors","Surveys and Questionnaires","Treatment Outcome","Young Adult"],"meshMinor":["Adult","Aged","BRCA1 Protein","BRCA2 Protein","Case-Control Studies","Chi-Square Distribution","DNA Mutational Analysis","Female","Fertility","Fertility Agents, Female","Fertilization in Vitro","Genetic Predisposition to Disease","Humans","Infertility","Insemination, Artificial","Logistic Models","Middle Aged","Multivariate Analysis","Odds Ratio","Ovarian Neoplasms","Pregnancy","Risk Assessment","Risk Factors","Surveys and Questionnaires","Treatment Outcome","Young Adult"],"genes":["BRCA1","BRCA2 mutation","estrogen receptor","gonadotropin","BRCA1","BRCA2 mutation","BRCA1","BRCA2 mutation","BRCA mutation"],"organisms":["9606","9606","9606"],"publicationTypes":["Journal Article","Multicenter Study","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov\u0027t"],"abstract":"To evaluate the relationship between use of fertility medication (i.e., selective estrogen receptor [ER] modulator, gonadotropin, or other) or infertility treatment (i.e., IVF or IUI) and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.\nA matched case-control study of 941 pairs of BRCA1 or BRCA2 mutation carriers with and without a diagnosis of ovarian cancer.\nGenetic clinics.\nDetailed information regarding treatment of infertility was collected from a routinely administered questionnaire.\nNone.\nConditional logistic regression was used to estimate odds ratios and 95% confidence intervals associated with fertility treatment.\nThere was no significant relationship between the use of any fertility medication or IVF treatment (odds ratio, 0.66; 95% confidence interval 0.18-2.33) and the subsequent risk of ovarian cancer.\nOur findings suggest that treatment for infertility does not significantly increase the risk of ovarian cancer among women with a BRCA mutation.","title":"Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.","pubmedId":"26698676"}